Evidence map›Paper›PMID 42352882›Full record

ArticleInternational journal of molecular sciences2026

Integrated Bulk and Single-Cell Transcriptomic Analysis Followed by Clinical Validation Reveal Programmed Cell Death-Related Shared Molecular Signatures in OA and MDD.

Jihua Liu, Zehao Hu, Zixuan Xu, Tao Xiao, Qiuxuan Huang, Liangji Liu, Zenan Wu

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jihua LiuSchool of Clinical Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
Zehao HuThe Second Clinical College, Guangzhou University of Traditional Chinese Medicine, Guangzhou 510000, China.ORCID 0000-0003-2341-1016
Zixuan XuSchool of Clinical Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
Tao XiaoSchool of Clinical Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
Qiuxuan HuangThe Second Clinical College, Guangzhou University of Traditional Chinese Medicine, Guangzhou 510000, China.
Liangji LiuSchool of Clinical Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China.
Zenan WuSchool of Clinical Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China.ORCID 0000-0002-6298-4688

Funding

The Qihuang Scholar Cultivation Project (Leading Talents of Traditional Chinese Medicine) from the National Administration of Traditional Chinese Medicine document number NATCM Personnel & Education Letter [2025] No. 182The Science and Technology Project of the Education Department of Jiangxi Province GJJ2400805The Youth Project of the Health Commission of Jiangxi Province 20252BAC200569
6 · The paper itself

Abstract

Osteoarthritis (OA) and major depressive disorder (MDD) share inflammatory and oxidative stress pathways, but the role of programmed cell death (PCD) in their comorbidity remains unclear. This study used independent OA synovial and MDD peripheral blood transcriptomic datasets-not a unified comorbid discovery cohort-to identify candidate PCD-related molecular signatures commonly dysregulated in both conditions. Transcriptomic data from OA synovium and MDD brain tissues were obtained from GEO (six training [three OA synovial and three MDD peripheral-blood], seven validation, and two single-cell RNA-seq datasets). Differentially expressed genes (DEGs) were identified, and PCD-related DEGs were screened. Machine learning (LASSO, SVM-RFE, Random Forest) was used to identify hub PCD-DEGs from the OA training set. WGCNA identified MDD-associated modules for comorbidity-gene selection. Functional enrichment, immune infiltration, scRNA-seq localization, and clinical validation (qRT-PCR/WB) were performed. From the OA cohort, four hub PCD-DEGs (CDKN1A, CX3CR1, INHBB, RHOB) showed moderate diagnostic value for OA (nomogram AUC = 0.82). Eight candidate genes (VAMP8, PDK4, P2RX4, ITM2C, IL10RA, HSP90AA1, CTSO, CRIP1) were commonly dysregulated across both OA and MDD datasets. Immune infiltration revealed upregulated B memory cells, plasma cells, Tregs, and neutrophils in OA, and neutrophils in MDD. scRNA-seq localized CDKN1A/RHOB to OA synovial cells and HSP90AA1/ITM2C to MDD neurons. Enrichment analyses highlighted TNF signaling, apoptosis, and stress responses in both diseases. An independent OA-MDD clinical cohort confirmed differential expression of CDKN1A, RHOB, ITM2C, and HSP90AA1. This study identifies four PCD-related hub genes associated with OA and eight candidate comorbidity genes showing common dysregulation across OA and MDD datasets and in an independent clinical cohort. These findings generate hypotheses about shared inflammatory pathways linking OA and MDD. As these associations derive from independent disease-specific cohorts rather than a true comorbid discovery cohort, they represent candidate signatures requiring functional validation rather than established mechanisms.

Indexed as

ApoptosisMajor Depressive DisorderOsteoarthritisTranscriptomeGene Expression ProfilingGene Regulatory NetworksHumansSingle-Cell AnalysisSingle-Cell Gene Expression AnalysisSynovial Membranebioinformaticscomorbidityimmune infiltrationmajor depressive disorderosteoarthritisprogrammed cell death

Identifiers

PMID42352882
PMCPMC13300034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.